fentanyl has been researched along with Lung Diseases in 19 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Lung Diseases: Pathological processes involving any part of the LUNG.
Excerpt | Relevance | Reference |
---|---|---|
"The investigation of gas exchange, central hemodynamics and real oxygen transport has shown expediency of using ether and fluothane as main anesthetic drugs in operations on the lungs in patients with a compensated form of chronic pulmonary respiratory insufficiency." | 3.67 | [Clinico-physiological substantiation of using various methods of anesthesia in operations on the lungs in patients with chronic respiratory insufficiency]. ( Zverev, VV, 1985) |
"To analyse the effects of combined acupuncture anesthesia on surgical dosage and serum interleukin-4 (IL-4), interleukin-10 (IL-10) of pneumonectomy patients." | 2.87 | Effect of Combined Acupuncture Anesthesia on Surgical Dosage and Serum IL-4, IL-10 of Pneumonectomy Patients. ( Shi, X; Xie, D; Zhang, Y, 2018) |
"Fentanyl (20 μg) was administered to the patients just before the examination, and fentanyl (10 μg) and midazolam (1 mg) were added as needed during the procedure." | 1.43 | Safety and discomfort during bronchoscopy performed under sedation with fentanyl and midazolam: a prospective study. ( Hotta, K; Kiura, K; Kubo, T; Minami, D; Ninomiya, T; Ohashi, K; Sato, A; Tabata, M; Takigawa, N; Tanimoto, M; Watanabe, H, 2016) |
"Propofol was administered with a target controlled infusion setting with the target blood concentration of 10 micrograms." | 1.32 | [Propofol anesthesia for fetal sedation]. ( Kubo, K; Murao, K; Nakao, S; Ohashi, A; Shingu, K; Takeyasu, A, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.79) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 7 (36.84) | 29.6817 |
2010's | 5 (26.32) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xie, D | 1 |
Shi, X | 1 |
Zhang, Y | 1 |
Minami, D | 1 |
Takigawa, N | 1 |
Watanabe, H | 1 |
Ninomiya, T | 1 |
Kubo, T | 1 |
Ohashi, K | 1 |
Sato, A | 1 |
Hotta, K | 1 |
Tabata, M | 1 |
Tanimoto, M | 1 |
Kiura, K | 1 |
Kurihara, Y | 1 |
Shime, N | 1 |
Miyazaki, T | 1 |
Hashimoto, S | 1 |
Tanaka, Y | 1 |
Biedrzycki, OJ | 1 |
Bevan, D | 1 |
Lucas, S | 1 |
Amr, YM | 1 |
Yousef, AA | 1 |
Alzeftawy, AE | 1 |
Messbah, WI | 1 |
Saber, AM | 1 |
Grannis, FW | 1 |
Quintard, H | 1 |
Tran-Marsalla, L | 1 |
Esquirole, C | 1 |
Ichai, C | 1 |
Guha, A | 1 |
Scawn, ND | 1 |
Rogers, SA | 1 |
Pennefather, SH | 1 |
Russell, GN | 1 |
Hansen, LN | 1 |
Ravn, JB | 1 |
Yndgaard, S | 1 |
Hung, CJ | 1 |
Liu, FY | 1 |
Shaiu, YC | 1 |
Kao, A | 1 |
Lin, CC | 1 |
Lee, CC | 1 |
Kubo, K | 1 |
Murao, K | 1 |
Takeyasu, A | 1 |
Ohashi, A | 1 |
Nakao, S | 1 |
Shingu, K | 1 |
Sanborn, PA | 1 |
Michna, E | 1 |
Zurakowski, D | 1 |
Burrows, PE | 1 |
Fontaine, PJ | 1 |
Connor, L | 1 |
Mason, KP | 1 |
Major, CP | 1 |
Greer, MS | 1 |
Russell, WL | 1 |
Roe, SM | 1 |
Bimston, DN | 1 |
McGee, JP | 1 |
Liptay, MJ | 1 |
Fry, WA | 1 |
Berger, S | 1 |
Murr, R | 1 |
Schürer, L | 1 |
Enzenbach, R | 1 |
Peter, K | 1 |
Baethmann, A | 1 |
Baktai, G | 1 |
Székely, E | 1 |
Márialigeti, T | 1 |
Kovács, L | 1 |
Zverev, VV | 1 |
Bergmann, H | 1 |
Shanin, IuN | 1 |
Rudenko, MI | 1 |
Volkov, IuN | 1 |
Matusevich, MIa | 1 |
Zvegintsev, VN | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of the Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion on the Quality of Postoperative Recovery in Patients Undergoing VATS Lobectomy[NCT05930405] | 252 participants (Anticipated) | Interventional | 2023-10-01 | Recruiting | |||
Role of Scheduled Intravenous Acetaminophen for Postoperative Pain Management in an Enhanced Recovery After Surgery (ERAS) Population: A Prospective, Randomized, Double-Blind and Placebo-Controlled Clinical Trial[NCT03198871] | Phase 4 | 180 participants (Actual) | Interventional | 2018-05-24 | Completed | ||
Can Medical Clowns Prevent the Usage of Sedation During the Performance of EEG in Young Children[NCT05257096] | 100 participants (Anticipated) | Interventional | 2019-05-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Number of patients who score greater than a 4 on the 0-8 point ICDSC scale to assess delirium scores. 8 separate levels of signs for delirium assessed (1. altered level of consciousness, 2. inattention, 3. disorientation, 4. hallucination, delusion, or psychosis, 5. psychomotor agitation or retardation, 6. inappropriate speech or mood, 7. sleep-wake cycle disturbance, 8. symptom fluctuation), with 0 points awarded when patient does not exhibit above signs of delirium and 1 point awarded per confirmed sign of delirium. Score then totaled, 0 = normal, 1-3 = subsyndromal delirium, 4-8 = delirium. (NCT03198871)
Timeframe: The delirium scores will first be measured every 12 hours for 72 hours after surgery.
Intervention | Participants (Count of Participants) |
---|---|
Acetaminophen Injectable Product | 0 |
Sodium Chloride 0.9%, Intravenous | 0 |
If the patient is readmitted to the hospital after being fully discharged, the event will be recorded. (NCT03198871)
Timeframe: From the time of consent until 30 days post-operatively
Intervention | Participants (Count of Participants) |
---|---|
Acetaminophen Injectable Product | 9 |
Sodium Chloride 0.9%, Intravenous | 10 |
Number of patients with unsatisfactory pain relief defined as average numeric rating scale (NRS) more than 5 will be compared between the two groups. This may include patients using IVPCA for pain relief during the first 48 hours postoperative. (NCT03198871)
Timeframe: PACU admission every thirty minutes until discharge to the floor and thereafter every four hours for first 24-hour, then every six hours until 48 hours and then every twelve hours until 72 hours postoperatively.
Intervention | Participants (Count of Participants) |
---|---|
Acetaminophen Injectable Product | 33 |
Sodium Chloride 0.9%, Intravenous | 42 |
The time it takes for the patient to successfully ambulate post-surgery will be measured. (NCT03198871)
Timeframe: From date of PACU admission until the date of first documented ambulation, assessed up to 72 hours postoperatively
Intervention | hours (Median) |
---|---|
Acetaminophen Injectable Product | 18.82 |
Sodium Chloride 0.9%, Intravenous | 17.38 |
The time it takes for the first bowel movement postoperatively will be measured. (NCT03198871)
Timeframe: From time patient left operating room until the time of first documented bowel movement, assessed up to hospital discharge
Intervention | hours (Median) |
---|---|
Acetaminophen Injectable Product | 46.30 |
Sodium Chloride 0.9%, Intravenous | 64.66 |
The time it takes for the patient to be fully discharged from the hospital post-surgery will be measured. (NCT03198871)
Timeframe: From date of randomization until the date of hospital discharge or 30 days postoperatively, whichever comes first
Intervention | days (Median) |
---|---|
Acetaminophen Injectable Product | 4.08 |
Sodium Chloride 0.9%, Intravenous | 4.94 |
The time it takes for the patient to ingest orally post-surgery will be measured. (NCT03198871)
Timeframe: From date of randomization until the date of first documented oral intake, assessed up to 72 hours postoperatively
Intervention | hours (Median) |
---|---|
Acetaminophen Injectable Product | 12.15 |
Sodium Chloride 0.9%, Intravenous | 9.40 |
The time from PACU admission to PACU discharge to the floor will be measured. (NCT03198871)
Timeframe: From time of PACU admission until the time of discharge, assessed up to 24 hours postoperatively
Intervention | minutes (Median) |
---|---|
Acetaminophen Injectable Product | 129.00 |
Sodium Chloride 0.9%, Intravenous | 152.50 |
Overall patient satisfaction as well as satisfaction relating to pain management and cost analyses will be measured. These will be measured with a numerical rating scale (NRS) with 0- being worst satisfaction and 10 - best satisfaction. (NCT03198871)
Timeframe: These measurements will be taken at time of discharge up to 30 days, whichever comes first
Intervention | score on a scale (Median) | |
---|---|---|
Patient satisfaction score, overall | Patient Satisfaction score, pain management | |
Acetaminophen Injectable Product | 10 | 10 |
Sodium Chloride 0.9%, Intravenous | 10 | 10 |
Frequency of emesis and rescue antiemetic requirement will be documented (NCT03198871)
Timeframe: These will be evaluated from the time of PACU admission until 72 hours postoperatively.
Intervention | Participants (Count of Participants) | |
---|---|---|
Emesis incidence 0-72 hours | Antiemetic use | |
Acetaminophen Injectable Product | 12 | 31 |
Sodium Chloride 0.9%, Intravenous | 14 | 45 |
Nausea will be evaluated by nausea score from 0 to 10, with 0 equaling no nausea and 10 equaling the worst nausea imaginable. (NCT03198871)
Timeframe: These will be evaluated from the time of PACU admission until 72 hours postoperatively.
Intervention | score on a scale (Mean) | |||||
---|---|---|---|---|---|---|
Nausea score POD 1 (am visit) | Nausea score POD 1 (pm visit) | Nausea score POD 2 (am visit) | Nausea score POD 2 (pm visit) | Nausea score POD 3 (am visit) | Nausea score POD 3 (pm visit) | |
Acetaminophen Injectable Product | 1.13 | 0.49 | 0.71 | 0.55 | 0.32 | 0.56 |
Sodium Chloride 0.9%, Intravenous | 0.60 | 0.92 | 0.75 | 0.69 | 0.66 | 0.78 |
Survey to assess patient's overall health (via a combination of mental and physical health assessment) at 30 days post-discharge. Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12). The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations). The United States population average PCS-12 and MCS-12 are both 50 points. The United States population standard deviation is 10 points. So each 10 increment of 10 points above or below 50, corresponds to one standard deviation away from the average (NCT03198871)
Timeframe: These measurements will take place at 30-days post hospital discharge
Intervention | Z-scores (difference compared to the pop (Median) | |
---|---|---|
SF 12 Physical score | SF 12 Mental score | |
Acetaminophen Injectable Product | 38.72 | 54.02 |
Sodium Chloride 0.9%, Intravenous | 38.07 | 52.08 |
Rescue analgesia will be given according to institutional pain management protocol. Unit of Measure recorded as OME (Oral Morphine Equivalent) consumption in mg. (NCT03198871)
Timeframe: From time of PACU admission until the time of discharge and 72-hours postoperatively, whichever comes first
Intervention | mg (Median) | ||||
---|---|---|---|---|---|
0-24 hours | 24-48 hours | 48-72 hours | 0-48 hours | 0-72 hours | |
Acetaminophen Injectable Product | 27.4 | 31.3 | 30 | 74 | 105.00 |
Sodium Chloride 0.9%, Intravenous | 36 | 45 | 37.5 | 88.8 | 127.1 |
2 reviews available for fentanyl and Lung Diseases
Article | Year |
---|---|
Fatal overdose due to prescription fentanyl patches in a patient with sickle cell/beta-thalassemia and acute chest syndrome: A case report and review of the literature.
Topics: Accidents; Acute Disease; Administration, Cutaneous; Adult; Analgesics, Opioid; beta-Thalassemia; Dr | 2009 |
[Indications and contraindications for neuroleptoanalgesia].
Topics: Abdomen; Analgesics; Animals; Benperidol; Eye Diseases; Fentanyl; Haloperidol; Humans; Isonipecotic | 1967 |
5 trials available for fentanyl and Lung Diseases
Article | Year |
---|---|
Effect of Combined Acupuncture Anesthesia on Surgical Dosage and Serum IL-4, IL-10 of Pneumonectomy Patients.
Topics: Acupuncture Analgesia; Anesthetics, Intravenous; Blood Pressure; Enzyme-Linked Immunosorbent Assay; | 2018 |
Effect of preincisional epidural fentanyl and bupivacaine on postthoracotomy pain and pulmonary function.
Topics: Adult; Aged; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Blood Glucose; Bupivacaine | 2010 |
Gastric emptying in post-thoracotomy patients receiving a thoracic fentanyl-bupivacaine epidural infusion.
Topics: Aged; Aged, 80 and over; Analgesia, Epidural; Anesthetics, Combined; Anesthetics, Intravenous; Anest | 2002 |
Continuous paravertebral extrapleural infusion for post-thoracotomy pain management.
Topics: Anesthesia, Epidural; Anesthetics, Local; Bupivacaine; Catheterization; Fentanyl; Forced Expiratory | 1999 |
Use of midazolam ('Dormicum') and flumazenil ('Anexate') in paediatric bronchology.
Topics: Anesthesia; Atropine; Bronchoscopy; Child, Preschool; Chronic Disease; Drug Administration Schedule; | 1992 |
12 other studies available for fentanyl and Lung Diseases
Article | Year |
---|---|
Safety and discomfort during bronchoscopy performed under sedation with fentanyl and midazolam: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Bronchoscopy; Female; Fentanyl; Hemodynamics; Humans; Hypnotics and | 2016 |
Clinical and hemodynamic factors associated with the outcome of early extubation attempts after right heart bypass surgery.
Topics: Analgesics, Opioid; Anesthesia, General; Cardiotonic Agents; Female; Fentanyl; Heart Bypass, Right; | 2009 |
Invited commentary.
Topics: Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Carbon Dioxide; Double-Bli | 2010 |
[Economic and clinical impact of a controlled sedation procedure in an intensive care unit].
Topics: Adult; Aged; Clinical Protocols; Conscious Sedation; Costs and Cost Analysis; Critical Care; Databas | 2012 |
Early extubation after single-lung transplantation: analysis of the first 106 cases.
Topics: Adult; Aged; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Combined; Female; Fentanyl; Force | 2003 |
Assessing transient pulmonary injury induced by volatile anesthetics by increased lung uptake of technetium-99m hexamethylpropylene amine oxime.
Topics: Adult; Aged; Anesthetics, Inhalation; Anesthetics, Intravenous; Endothelium, Vascular; Female; Fenta | 2003 |
[Propofol anesthesia for fetal sedation].
Topics: Adult; Anesthesia, Intravenous; Anesthesia, Obstetrical; Anesthetics, Intravenous; Cesarean Section; | 2004 |
Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations.
Topics: Cardiovascular System; Child, Preschool; Chloral Hydrate; Conscious Sedation; Diagnostic Imaging; Fe | 2005 |
Postoperative pulmonary complications and morbidity after abdominal aneurysmectomy: a comparison of postoperative epidural versus parenteral opioid analgesia.
Topics: Aged; Aged, 80 and over; Analgesia; Analgesia, Epidural; Analgesics, Opioid; Aortic Aneurysm, Abdomi | 1996 |
Brain surface pO2 and rCBF in rabbits with a focal cerebral lesion and pulmonary hypoxia under fentanyl-, isoflurane- or thiopental-anesthesia.
Topics: Anesthesia, General; Animals; Brain; Brain Injuries; Cerebral Cortex; Fentanyl; Hypoxia; Isoflurane; | 1992 |
[Clinico-physiological substantiation of using various methods of anesthesia in operations on the lungs in patients with chronic respiratory insufficiency].
Topics: Anesthesia, General; Chronic Disease; Ether; Fentanyl; Halothane; Hemodynamics; Humans; Lung Disease | 1985 |
[Neuroleptanalgesia in surgery on the organs of the chest].
Topics: Adolescent; Adult; Aged; Benperidol; Fentanyl; Humans; Lung Diseases; Methods; Middle Aged; Mitral V | 1969 |